Tranza
Products / Human DivisionOverview
Tranexamic Acid 500mg Injection Stops / Reduces unwanted bleeding Preserve the fibrin matrix Increase the tensile strength of clot Indications: Surgical / Post-operative hemorrhage Menorrhagia and Intermenstrual bleeding Gastrointestinal bleeding.
Active Ingredients:
Each 5 ml ampule contains:
Tranexamic acid ………… 500 mg
Uses / Indications: To treat Hemorrhage caused by general or local fibrinolysis.
Benefits: Tranza reduces conversion of plasminogen to plasmin, preventing fibrin degradation and preserving the framework of fibrin’s matrix structure
Dosage and Administration:
As prescribed by physicians.
Presentation: 5ml x 10’s
Request for Proposal
Tranza Tablet
Tranza – Tranexamic Acid
500mg Injection
- Stops / Reduces unwanted bleeding
- Preserve the fibrin matrix
- Increase the tensile strength of clot
Indications:
Surgical / Post-operative hemorrhage
Menorrhagia and Intermenstrual bleeding
Gastrointestinal bleeding
Hemorrhagic urinary bleeding
Hemorrhagic complications in association with thrombolytic therapy
Dosage and Administration
Adult
Local Fibrinolysis:
5-10ml (500-1000mg) by slow I.V Injection (1ml/min), 2-3 times a day.
General Fibrinolysis:
body weight
Paediatrics:
From one year for the current approved indications, the dosage is 20mg/kg/day.
Renal Failure:
Due to the risk of accumulation, the dose should be reduced according to the following table:
| Serum Creatinine | Dose iv | Dose Frequency |
| 120-249 mcmol/I | 10mg/kg | BW every 12 hours |
| 250-500mcmol/I | 10mg/kg | BW every 24 hours |
| >500mcmol/I | 5mg/kg | BW every 24 hours |
